BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 19265095)

  • 21. Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation?
    Tieleman RG; Van Gelder IC; Bosker HA; Kingma T; Wilde AA; Kirchhof CJ; Bennekers JH; Bracke FA; Veeger NJ; Haaksma J; Allessie MA; Crijns HJ
    Heart Rhythm; 2005 Mar; 2(3):223-30. PubMed ID: 15851308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs.
    Schilling RJ
    Heart; 2010 Mar; 96(5):333-8. PubMed ID: 19910286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
    Aronow WS
    Cardiol Rev; 2008; 16(4):181-8. PubMed ID: 18562808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial fibrillation after cardiac surgery: pathophysiology and treatment.
    Palin CA; Kailasam R; Hogue CW
    Semin Cardiothorac Vasc Anesth; 2004 Sep; 8(3):175-83. PubMed ID: 15375479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
    Singh SN; Tang XC; Reda D; Singh BN
    Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Facilitating electrical cardioversion of persistant atrial fibrillation by antiarrhythmic drugs: update on clinical trial results.
    Sung RJ
    Card Electrophysiol Rev; 2003 Sep; 7(3):300-3. PubMed ID: 14739733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.
    Hayashi M; Tanaka K; Kato T; Morita N; Sato N; Yasutake M; Kobayashi Y; Takano T
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):740-7. PubMed ID: 16050832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute management of atrial fibrillation: from emergency department to cardiac care unit.
    Beck H; See VY
    Cardiol Clin; 2012 Nov; 30(4):567-89. PubMed ID: 23102033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physician variation in the management of patients with atrial fibrillation.
    Lip GY; Zarifis J; Watson RD; Beevers DG
    Heart; 1996 Feb; 75(2):200-5. PubMed ID: 8673762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
    Márk L; Erdej F; Dani G; Borbély M; Sziklai G; Nagy E; Hajdara I; Katona A
    Orv Hetil; 2004 May; 145(19):1001-6. PubMed ID: 15181735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Remodeling by atrial fibrillation and clinical implications for cardioversion].
    Ehrlich JR; Götte A
    Dtsch Med Wochenschr; 2011 Oct; 136(43):2212-6. PubMed ID: 22009176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment strategies for atrial fibrillation.
    Jung F; DiMarco JP
    Am J Med; 1998 Mar; 104(3):272-86. PubMed ID: 9552091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.
    Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G
    Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Atrila fibrillation: a review].
    Brunckhorst CB; Holzmeister J; Scharf Ch; Binggeli Ch; Hellermann JP; Duru F
    Praxis (Bern 1994); 2004 May; 93(19):803-15. PubMed ID: 15185487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Atrial Fibrillation.
    Zamani P; Verdino RJ
    J Intensive Care Med; 2015 Dec; 30(8):484-98. PubMed ID: 24828991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial fibrillation: conventional wisdom reappraised.
    Blazing MA; Morris JJ
    Heart Dis Stroke; 1992; 1(2):78-84. PubMed ID: 1344090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Atrial fibrillation: always cardioversion? No].
    Di Pasquale G; Biancoli S; Sassone B; Pancaldi LG
    Ital Heart J Suppl; 2002 Jan; 3(1):81-90. PubMed ID: 11899578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Stroke and other thromboembolic complications of atrial fibrillation. Part VI. Choice of optimal approach and drugs for prevention of stroke].
    Preobrazhenskiĭ DV; Sidorenko BA; Kiktëv VG; Batyraliev TA; Pershukov IV
    Kardiologiia; 2005; 45(1):84-93. PubMed ID: 15699946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of atrial fibrillation in the critically ill].
    Willich T; Hammwöhner M; Goette A
    Med Klin Intensivmed Notfmed; 2012 Jun; 107(5):368-76. PubMed ID: 22689259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.